ARTICLE | Clinical News
Factor VIII drugs regulatory update
August 22, 2016 7:00 AM UTC
EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) began a review of approved Factor VIII drugs to treat hemophilia A to evaluate the risk of patients developing inhibitors when starting treatme...